Lurasidone Hydrochloride Tablet
Product Images NDC 68180-674

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 68180-674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 01)

Chemical structure of lurasidone hydrochloride, showing its molecular framework including rings, nitrogen, oxygen, sulfur atoms, and the associated hydrochloride (HCl) group.*

FDA Label Image

Image-02 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 02)

A pharmacokinetic impact chart showing the effect of various drugs on lurasidone hydrochloride. The graph plots fold change and 90% confidence intervals in Cmax and AUC relative to lurasidone alone, with interacting drugs including strong CYP3A4 inhibitor ketoconazole, moderate CYP3A4 inhibitor diltiazem, strong CYP3A4 inducer rifampin, and lithium. The x-axis represents change relative to lurasidone alone from -4 to 4.*

FDA Label Image

Image-03 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 03)

A horizontal forest plot showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax, AUC, and Ctrough of various interacting drugs versus when administered alone. Drugs include Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium. The x-axis represents change relative to interactive drug alone, ranging from -1.0 to 1.0.*

FDA Label Image

Image-04 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 04)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC values in patients with varying degrees of renal and hepatic impairment, as well as population subgroups by gender and race. The x-axis represents change relative to reference, with data points and error bars plotted accordingly.*

FDA Label Image

Image-06 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 05)

Label for Lurasidone Hydrochloride Tablets, 20 mg strength, oral dosage form. The label shows a quantity of 30 tablets and is labeled for prescription use only (Rx only). Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and by Lupin Limited, Nagpur, India. Storage instructions and usual dosage guidance are also indicated.*

FDA Label Image

Image-07 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 06)

Label for Lurasidone Hydrochloride Tablets, 40 mg, oral tablets packaged in a quantity of 30. The label includes instructions for the pharmacist to dispense a medication guide with the product. It is manufactured by Lupin Limited in India and labeled for Lupin Pharmaceuticals, Inc., Baltimore, Maryland. Storage instructions specify controlled room temperature conditions.*

FDA Label Image

Image-08 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 07)

Label for Lurasidone Hydrochloride Tablets 60 mg by Lupin Pharmaceuticals. It specifies the tablet strength as 60 mg, prescription-only status, and package size of 30 tablets. The label includes storage instructions, manufacturing details from Lupin Limited in India, and dispensing guidance for pharmacists.*

FDA Label Image

Image-09 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 08)

Label for Lurasidone Hydrochloride Tablets 80 mg, oral tablets in a 30-tablet package. The label indicates the product is manufactured for Lupin Pharmaceuticals, Inc. and by Lupin Limited in India. It includes storage instructions and a note for pharmacists to dispense the medication guide separately.*

FDA Label Image

Image-08 (2ac9a6f6 F9f1 4ffb Beb6 Be3ffa53bff5 09)

Label for Lurasidone Hydrochloride Tablets 120 mg oral tablets, supplied in a 30-tablet package. The label includes storage instructions and dispensing guidance, states the product is for prescription use only, and identifies Lupin Pharmaceuticals, Inc. as the labeler and Lupin Limited in India as the manufacturer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.